| [1] |
中华人民共和国国家卫生健康委员会, 国家中医药管理局. 流行性感冒诊疗方案(2020年版)[J]. 中华临床感染病杂志,2020,13(6):401-405, 411.
|
| [2] |
Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa[J]. Clin Infect Dis,2019,68(6):895-902.
|
| [3] |
Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study[J]. Lancet,2018,391(10127):1285-1300.
|
| [4] |
Li L, Liu Y, Wu P, et al. Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study[J]. Lancet Public Health,2019,4(9):e473-e481.
|
| [5] |
国家卫生健康委. 国家卫生健康委办公厅关于印发感染性疾病等4个专业医疗质量控制指标(2023年版)的通知[EB/OL]. (2023-11-13).
URL
|
| [6] |
Fjelltveit EB, Cox RJ, Østensjø J, et al. Point-of-care influenza testing impacts clinical decision, patient flow, and length of stay in hospitalized adults[J]. J Infect Dis,2022,226(1):97-108.
|
| [7] |
Katzen J, Kohn R, Houk JL, et al. Early oseltamivir after hospital admission is associated with shortened hospitalization: A 5-year analysis of oseltamivir timing and clinical outcomes[J]. Clin Infect Dis,2019,69(1):52-58.
|
| [8] |
Venkatesan S, Myles PR, Bolton KJ, et al. Neuraminidase inhibitors and hospital length of stay: A Meta-analysis of individual participant data to determine treatment effectiveness among patients hospitalized with nonfatal 2009 pandemic influenza A (H1N1) virus Infection[J]. J Infect Dis,2020,221(3):356-366.
|
| [9] |
Swets MC, Russell CD, Harrison EM, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses[J]. Lancet,2022,399(10334):1463-1464.
|
| [10] |
Liu YF, Gao Y, Chen MF, et al. Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China[J]. BMC Infect Dis,2013,13:309.
|
| [11] |
Lampejo T. Influenza and antiviral resistance: an overview[J]. Eur J Clin Microbiol Infect Dis,2020,39(7):1201-1208.
|
| [12] |
Stewart RJ, Flannery B, Chung JR, et al. Influenza antiviral prescribing for outpatients with an acute respiratory illness and at high risk for influenza-associated complications during 5 influenza Seasons-United States, 2011-2016[J]. Clin Infect Dis,2018,66(7):1035-1041.
|
| [13] |
Sutton SS, Magagnoli J, Cummings T, et al. Association between the use of antibiotics, antivirals, and hospitalizations among patients with laboratory-confirmed Influenza[J]. Clin Infect Dis,2021,72(4):566-573.
|
| [14] |
Public Health England. PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza[EB/OL]. Version 9.1, 2019.
|
| [15] |
Vos LM, Bruning AHL, Reitsma JB, et al. Rapid molecular tests for influenza, respiratory syncytial virus, and other respiratory viruses: A systematic review of diagnostic accuracy and clinical impact studies[J]. Clin Infect Dis,2019,69(7):1243-1253.
|
| [16] |
Ison MG, Linder JA. Optimizing Use of Antibiotics and Antivirals in Ambulatory Patients With Influenza[J]. Clin Infect Dis,2021,72(4):574-575.
|